Table 5.
Drug resistance of E. coli (ESBL +/-) in mild and severe patients.
| ESBLs + (n=34) | ESBLs - (n=8) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mild | Severe | P | Mild | Severe | P | |||||
| n=18 | % | n=16 | % | n=1 | % | n=7 | % | |||
| Ampicillin | 14 | 77.78 | 15 | 93.75 | 0.1893 | 0 | 0 | 4 | 57.14 | NA |
| Ampicillin-sulbactam | 12 | 66.67 | 13 | 81.25 | 0.3360 | 0 | 0 | 2 | 28.57 | NA |
| Aztreonam | 18 | 100 | 11 | 68.75 | 0.0102 | 0 | 0 | 1 | 14.29 | NA |
| Cefazolin | 16 | 88.89 | 16 | 100 | 0.1693 | 0 | 0 | 1 | 14.29 | NA |
| Ceftriaxone | 16 | 88.89 | 16 | 100 | 0.1693 | 0 | 0 | 1 | 14.29 | NA |
| Ceftazidime | 6 | 33.33 | 8 | 50 | 0.3243 | 0 | 0 | 1 | 14.29 | NA |
| Cefotetan | 0 | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | NA |
| Cefepime | 9 | 50 | 9 | 56.25 | 0.7155 | 0 | 0 | 0 | 0 | NA |
| Piperacillin/tazobactam sodium | 2 | 11.11 | 0 | 0 | NA | 0 | 0 | 0 | 0 | NA |
| Imipenem | 0 | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | NA |
| Ertapenem | 0 | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | NA |
| Ciprofloxacin | 18 | 100 | 15 | 93.75 | 0.2817 | 1 | 100 | 3 | 42.86 | NA |
| Levofloxacin | 18 | 100 | 12 | 75 | 0.0239 | 1 | 100 | 3 | 42.86 | NA |
| Amikacin | 3 | 16.67 | 3 | 18.75 | 0.8736 | 0 | 0 | 0 | 0 | NA |
| Gentamicin | 12 | 66.67 | 7 | 43.75 | 0.1792 | 0 | 0 | 3 | 42.86 | NA |
| Tobramycin | 8 | 44.44 | 6 | 37.5 | 0.6813 | 0 | 0 | 2 | 28.57 | NA |
| Trimethoprim/sulfamethoxazole | 11 | 61.11 | 10 | 62.5 | NA | 1 | 100 | 4 | 57.14 | NA |